The integration of Oracle Argus enables QPS to better capture, manage, and report adverse events for regulatory requirements.

In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs.

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...

In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

NextTrial today announced the official launch of NextTrial One, a unified intelligence platform for life sciences designed to accelerate innovation and data-driven decision-making across ...

The BLA was resubmitted in 2025, after Atara and the FDA aligned on the criteria and addressed the initial CRL conditions.

Atara Biotherapeutics (NASDAQ: ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD).

The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...

Investigators from @hopkinskimmel (@wonjinho1, @DNSidiropoulos, @AmandaHuffPhD, @DrLizJaffee) create free atlas of ...

OCHIN, Reid Health, Trinity Health and UMass Memorial Health join the electronic health record vendor in a new federal ...